Detail page

Knowledge Web

Person

Marc Münter (1972-)

Name	Marc Münter
Time	1972- (Date of birth and death)
Place	Deutschland
Academic degree	Prof. Dr.
Variant	Marc Muenter Marc Wilhelm Münter M.W. Münter Marc W. Münter Marc W. Muenter
Further information	seit 1/2008 zuständiger Oberarzt für das Heidelberger Ionenstrahl-Therapiezentrum (HIT); jetzt Ärztlicher Direktor, Klinik für Strahlentherapie und Radioonkologie, Klinikum Stuttgart Diss. Medizinische Fakultät
Record type	Person
GND-Identifier	121295591
Record ID	121295591
Involved in show all Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN) Assessment of peri- and postoperative complications and Karnofsky-performance status in head and neck cancer patients after radiation or chemoradiation that underwent surgery with regional or free-flap reconstruction for salvage, palliation, or to improve function Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation alone regarding Event-Free Survival – CapRI-2 Morphologische und funktionelle Untersuchungen zu vaskulären Spätveränderungen nach stereotaktischer Bestrahlung des Rattengehirns

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Marc Münter (1972-)

Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma

Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma

The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents

The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT

Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response

Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Assessment of peri- and postoperative complications and Karnofsky-performance status in head and neck cancer patients after radiation or chemoradiation that underwent surgery with regional or free-flap reconstruction for salvage, palliation, or to improve function

Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT

Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol

Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study

Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study

RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab

A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation alone regarding Event-Free Survival – CapRI-2

Morphologische und funktionelle Untersuchungen zu vaskulären Spätveränderungen nach stereotaktischer Bestrahlung des Rattengehirns